Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prehospital antiemetic trial for nausea and vomiting
ACTRN12624000303549Phase 4Recruiting
- Sponsor
- Queensland Ambulance Service
- Start
- Feb 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ondansetron, droperidol and metoclopramide in Nausea and Vomiting (4 arms), sponsored by Queensland Ambulance Service. Primary endpoint: Reduction in nausea severity. Started Feb 2025; status: recruiting.
02
Drugs
ondansetrondroperidolmetoclopramide
03
Conditions
Nausea and Vomiting
Beyond the preview
Go deeper on ACTRN12624000303549.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12624000303549.